Strain Information | |
---|---|
Image | |
BRC No. | RBRC02137 |
Type | Targeted Mutation |
Species | Mus musculus |
Strain name | STOCK Olfr151<tm28(cre)Mom>/MomTyagRbrc |
Former Common name | M71-ires-Cre; M71-Cre |
H-2 Haplotype | |
ES Cell line | E14 [129P2/OlaHsd] |
Background strain | |
Appearance | |
Strain development | Developed by Peter Mombaerts, The Rockefeller University in 2004. The neo cassette was removed by crossing with Tg(ACTB-FLP) mice. |
Strain description | M71 (Olfr151) gene cre knock-in mice. An ires-Cre was inserted downstream of the coding sequence of Olfr151 gene. Homozygous mutant mice are viable and fertile. |
Colony maintenance | Homozygote x Homozygote [or Crossing to C57BL/6J(Crlj)] |
References | Mol Cell Neurosci, 38, 66-79 (2008). 18353676 Nature. 428(6981):393-9 (2004). 15042081 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |
---|---|
Gene info | Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Olfr151olfactory receptor 1519Olfr151<tm28Mom>targeted mutation 28, Peter MombaertsGA_x6K02T2PVTD-31408136-31407207, M71, MOR171-2 Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter Frtyeast FRT (flippase recombination target) site9Frt Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter IRESinternal ribosomal entry site (EMCV)9 Gene symbolGene nameChr.Allele symbolAllele nameCommon namesPromoter crePhage P1 Cre recombinase9cre |
Ordering Information | |
---|---|
Donor DNA | Encephalomyocarditis virus (EMCV) internal ribosomal entry site (ires), yeast FRT (flipase recombination target) site, mouse Olfr151 genomic DNA |
Research application | FLP/frt system General Purpose Neurobiology Research |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. The RECIPIENT of BIOLOGICAL RESOURCE must obtain a prior consent on use of it from Professor Peter Monbaerts, The Rockefeller University. If the RECIPIENT's research results in an invention based on the BIOLOGICAL RESOURCE, the RECIPIENT must contact DEPOSITOR to negotiate the treatment of such invention. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, the RECIPIENT must obtain a prior written consent from the DEPOSITOR. The RECIPIENT, which wishes to use the BIOLOGICAL RESOURCE for the purpose other than education or not-for-profit research, is requested to enter into a Material Transfer Agreement with Osaka University. |
Depositor | Takeshi Yagi (Osaka University) |
Strain Status | Frozen embryos Frozen sperm |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
|
BRC mice in Publications |
---|
No Data |